Quest diagnostics logo

AACR 2023 Annual Meeting

The annual American Association for Cancer Research (AACR) meeting is one of the largest and most respected cancer conferences in the world and a focal point of the cancer research community. And Haystack will be there!

This year’s event will take place April 14–19 in Orlando, Florida, with a special focus of advancing the frontiers of cancer science and medicine.

Stop by the Haystack Oncology booth (#1403) to learn more about how we’re using the next generation of ctDNA detection technology to uncover residual, recurrent, and resistant disease earlier than any other MRD test on the market. Haystack MRD™ is well-positioned to:

  • Enable more confident cancer treatment management 
  • Accelerate clinical trials 

We are excited to be part of this year’s AACR meeting and look forward to sharing our insights and innovations with cancer researchers and clinicians worldwide. 

Share:
Facebook
Twitter
LinkedIn
Email

Subscribe for updates

No spam, notifications only about new products, updates.
News and events

Haystack technology in action at ASCO 2024!

Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, has entered into a collaboration with Alliance Foundation Trials, LLC (AFT) for research use of Haystack Oncology’s personalized MRD technology (Haystack MRD™) to analyze therapeutic response and provide molecular insights for AFT’s

Follow us on social media

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Social: 

Visit Johns Hopkins School of Medicine to learn more.
Visit Johns Hopkins School of Medicine to learn more.
Visit Johns Hopkins School of Medicine to learn more.